Investigators will determine how best to measure and track symptoms of dysferlin deficiency, with the goal of defining outcome measures for use in clinical trials
Update (July 17, 2014): This story has been updated to reflect that recruitment for this study has been extended through Aug. 31, 2014; that Sarah Shira is now the person to contact at the Jain Foundation; and that the foundation is now located in Seattle.
A new zebrafish research model may speed myofibrillar myopathy research; published results of a gene transfer study in LGMD are now accessible
Update (Aug. 8, 2012): This story was updated to reflect the availability of a podcast on the dysferlin gene transfer study.
Zebrafish research models mimic myofibrillar myopathy
The following article contains items about: Friedreich's ataxia, Charcot-Marie-Tooth disease, myotonic muscular dystrophy type 1, amyotrophic lateral sclerosis, Emery-Dreifuss muscular dystrophy and distal muscular dystrophy (Miyoshi myopathy)
The following story includes items about: Becker muscular dystrophy, centronuclear myopathy, type 1A Charcot-Marie-Tooth disease, congenital muscular dystrophy, Duchenne muscular dystrophy, limb-girdle muscular dystrophy, Miyoshi myopathy (distal muscular dystrophy), type 1 myotonic muscular dystrophy, myotubular myopathy, nemaline myopathy, and spinal muscular atrophy
Scientists have identified a protein cluster that patches damaged muscle-fiber membranes in muscular dystrophy
Scientists in the United States and Japan have identified a three-protein cluster that reseals damaged muscle-fiber membranes. The findings, published June 5, 2009, in the Journal of Biological Chemistry, could have implications for development of treatments for muscular dystrophies.
Items in this article refer to clinical trials in: Duchenne muscular dystrophy, myasthenia gravis, Becker muscular dystrophy, limb-girdle muscular dystrophy, hypokalemic and hyperkalemic periodic paralysis, Pompe disease, FSH muscular dystrophy, Miyoshi distal muscular dystrophy, myotubular myopathy, congenital muscular dystrophy and ALS.
This article includes items about clinical trials in: Duchenne MD, limb-girdle MD, distal muscular dystrophy, and acid maltase deficiency.